These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22111225)

  • 1. [The Medical Products Agency should supervise blood production. Disagreement concerning men who had sexual contacts with men has brought matters to a head].
    Söderström T
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1894. PubMed ID: 22111225
    [No Abstract]   [Full Text] [Related]  

  • 2. The quality of blood products in Mississippi takes another leap forward.
    Jett PL
    J Miss State Med Assoc; 1999 Nov; 40(11):390-1. PubMed ID: 10568090
    [No Abstract]   [Full Text] [Related]  

  • 3. Red blood cells, plasma, and other new apheresis-derived blood products: improving product quality and donor utilization.
    Smith JW; Gilcher RO
    Transfus Med Rev; 1999 Apr; 13(2):118-23. PubMed ID: 10218235
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quality standards and quality control of plasma].
    Fürst G
    Beitr Infusionsther; 1991; 28():49-55. PubMed ID: 1725660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Checking of blood product in hospital].
    Girard A
    Transfus Clin Biol; 2004 Oct; 11(4):205-9. PubMed ID: 15564102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do we have a good blood supply?].
    Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Oct; 56(10):1349-51. PubMed ID: 24162028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Important points concerning quality control of blood products under the product liability law].
    Tasaki T; Ohto H
    Nihon Rinsho; 1997 Sep; 55(9):2214-8. PubMed ID: 9301279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood products].
    Montloin A
    Rev Infirm; 1992 Mar; 42(6):33-41. PubMed ID: 1598492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production and consumption of blood and blood products in Norway. Factors of quality assurance in transfusion medicine].
    Heier HE
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):18-22. PubMed ID: 8424244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.
    O'Mahony B; Turner A
    Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Safety of plasma products may be improved].
    Wahlberg T
    Lakartidningen; 1995 Dec; 92(51-52):4869-70. PubMed ID: 8544500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Labile blood products and their preparation].
    Chabanel A; Folléa G
    Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 15. The six questions of pathogen reduction technology: an overview of current opinions.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2008 Aug; 39(1):51-7. PubMed ID: 18614401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality and safety about hemapheresis practicing: from a self-evaluation of medical practices to a systematic risk management process].
    Lefèvre PA; Audat F; Giraud C; Roussel P
    Transfus Clin Biol; 2010 Apr; 17(2):69-80. PubMed ID: 20674436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing blood component donations.
    Fuller MJ
    Vox Sang; 2000; 78 Suppl 2():47-9. PubMed ID: 10938926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality control in autologous blood donation and transfusion].
    Dietrich G; Kretschmer V
    Beitr Infusionsther; 1991; 28():348-55. PubMed ID: 1725653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood components: indication and notice of transfusion].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.